298 related articles for article (PubMed ID: 27383398)
21. Adjuvant chemotherapy after neoadjuvant chemoradiation and curative resection for rectal cancer: is it necessary for all patients?
Jung KU; Kim HC; Park JO; Park YS; Park HC; Choi DH; Cho YB; Yun SH; Lee WY; Chun HK
J Surg Oncol; 2015 Mar; 111(4):439-44. PubMed ID: 25488390
[TBL] [Abstract][Full Text] [Related]
22. Circumferential resection margins and perineal complications after neoadjuvant long-course chemoradiotherapy followed by extralevator abdominoperineal excision of the rectum: Five years of activity at a single institution.
Gravante G; Miah A; Mann CD; Stephenson JA; Gani MA; Sharpe D; Norwood M; Boyle K; Miller A; Hemingway D
J Surg Oncol; 2016 Jul; 114(1):86-90. PubMed ID: 27076410
[TBL] [Abstract][Full Text] [Related]
23. Circumferential margin involvement after total mesorectal excision for mid or low rectal cancer: are all R1 resections equal?
Beaufrère A; Guedj N; Maggiori L; Patroni A; Bedossa P; Panis Y
Colorectal Dis; 2017 Nov; 19(11):O377-O385. PubMed ID: 28941054
[TBL] [Abstract][Full Text] [Related]
24. A circumferential resection margin of 1 mm is a negative prognostic factor in rectal cancer patients with and without neoadjuvant chemoradiotherapy.
Park JS; Huh JW; Park YA; Cho YB; Yun SH; Kim HC; Lee WY; Chun HK
Dis Colon Rectum; 2014 Aug; 57(8):933-40. PubMed ID: 25003288
[TBL] [Abstract][Full Text] [Related]
25. Rectal cancer: MR imaging before neoadjuvant chemotherapy and radiation therapy for prediction of tumor-free circumferential resection margins and long-term survival.
Wieder HA; Rosenberg R; Lordick F; Geinitz H; Beer A; Becker K; Woertler K; Dobritz M; Siewert JR; Rummeny EJ; Stollfuss JC
Radiology; 2007 Jun; 243(3):744-51. PubMed ID: 17463134
[TBL] [Abstract][Full Text] [Related]
26. Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging-defined locally advanced rectal cancer: impact on long-term clinical outcomes.
Gollins S; Sun Myint A; Haylock B; Wise M; Saunders M; Neupane R; Essapen S; Samuel L; Dougal M; Lloyd A; Morris J; Topham C; Susnerwala S
J Clin Oncol; 2011 Mar; 29(8):1042-9. PubMed ID: 21263095
[TBL] [Abstract][Full Text] [Related]
27. Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer.
Carruthers R; Tho LM; Brown J; Kakumanu S; McCartney E; McDonald AC
Colorectal Dis; 2012 Oct; 14(10):e701-7. PubMed ID: 22731833
[TBL] [Abstract][Full Text] [Related]
28. The Importance of a Minimal Tumor-Free Resection Margin in Locally Recurrent Rectal Cancer.
Alberda WJ; Verhoef C; Schipper ME; Nuyttens JJ; Rothbarth J; de Wilt JH; Burger JW
Dis Colon Rectum; 2015 Jul; 58(7):677-85. PubMed ID: 26200682
[TBL] [Abstract][Full Text] [Related]
29. Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?: Three Years' Follow-up Results of the Greccar-6 Randomized Multicenter Trial.
Lefèvre JH; Mineur L; Cachanado M; Denost Q; Rouanet P; de Chaisemartin C; Meunier B; Mehrdad J; Cotte E; Desrame J; Karoui M; Benoist S; Kirzin S; Berger A; Panis Y; Piessen G; Saudemont A; Prudhomme M; Peschaud F; Dubois A; Loriau J; Tuech JJ; Meurette G; Lupinacci R; Goasguen N; Creavin B; Simon T; Parc Y;
Ann Surg; 2019 Nov; 270(5):747-754. PubMed ID: 31634178
[TBL] [Abstract][Full Text] [Related]
30. Selective approach for upper rectal cancer treatment: total mesorectal excision and preoperative chemoradiation are seldom necessary.
Marinello FG; Frasson M; Baguena G; Flor-Lorente B; Cervantes A; Roselló S; Espí A; García-Granero E
Dis Colon Rectum; 2015 Jun; 58(6):556-65. PubMed ID: 25944427
[TBL] [Abstract][Full Text] [Related]
31. The prognostic impact of preoperative blood monocyte count in pathological T3N0M0 rectal cancer without neoadjuvant chemoradiotherapy.
Zhang LN; Xiao W; OuYang PY; You K; Zeng ZF; Ding PR; Pan ZZ; Xu RH; Gao YH
Tumour Biol; 2015 Sep; 36(10):8213-9. PubMed ID: 25994571
[TBL] [Abstract][Full Text] [Related]
32. Long-term outcome of local excision after preoperative chemoradiation for ypT0 rectal cancer.
Stipa F; Picchio M; Burza A; Soricelli E; Vitelli CE
Dis Colon Rectum; 2014 Nov; 57(11):1245-52. PubMed ID: 25285690
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcome of neoadjuvant chemoradiation in locally advanced rectal cancer at a tertiary hospital.
Yeung WW; Ma BB; Lee JF; Ng SS; Cheung MH; Ho WM; Tsang MW; Chu S; Lam DC; Mo FK
Hong Kong Med J; 2016 Dec; 22(6):546-55. PubMed ID: 27795447
[TBL] [Abstract][Full Text] [Related]
34. Is adjuvant chemotherapy necessary for patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery in locally advanced rectal cancer? Long-term analysis of 40 ypCR patients at a single center.
Zhou J; Qiu H; Lin G; Xiao Y; Wu B; Wu W; Sun X; Lu J; Zhang G; Xu L; Liu Y
Int J Colorectal Dis; 2016 Jun; 31(6):1163-8. PubMed ID: 27044403
[TBL] [Abstract][Full Text] [Related]
35. Outcome of neoadjuvant chemoradiation in MRI staged locally advanced rectal cancer: Retrospective analysis of 123 Chinese patients.
Lee SF; Chiang CL; Lee FAS; Wong YW; Poon CM; Wong FCS; Tung SY
J Formos Med Assoc; 2018 Sep; 117(9):825-832. PubMed ID: 29100742
[TBL] [Abstract][Full Text] [Related]
36. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision.
Lee JH; Jang HS; Kim JG; Cho HM; Shim BY; Oh ST; Yoon SC; Kim YS; Choi BO; Kim SH
Ann Surg Oncol; 2012 Apr; 19(4):1213-21. PubMed ID: 21935746
[TBL] [Abstract][Full Text] [Related]
37. Predictors of disease-free survival in rectal cancer patients undergoing curative proctectomy.
Stewart D; Yan Y; Mutch M; Kodner I; Hunt S; Lowney J; Birnbaum E; Read T; Fleshman J; Dietz D
Colorectal Dis; 2008 Nov; 10(9):879-86. PubMed ID: 19037929
[TBL] [Abstract][Full Text] [Related]
38. The significance of extramural venous invasion in R1 positive rectal cancer.
Ormsby NM; Bermingham HN; Joshi HM; Chadwick M; Samad A; Maitra D; Scott M; Kelly S; Whitmarsh K; Rajaganeshan R
Int J Colorectal Dis; 2017 Jan; 32(1):119-124. PubMed ID: 27695932
[TBL] [Abstract][Full Text] [Related]
39. Surgeon-Level Variation in Utilization of Local Staging and Neoadjuvant Therapy for Stage II-III Rectal Adenocarcinoma.
Swords DS; Skarda DE; Sause WT; Gawlick U; Cannon GM; Lewis MA; Scaife CL; Gygi JA; Tae Kim H
J Gastrointest Surg; 2019 Apr; 23(4):659-669. PubMed ID: 30706375
[TBL] [Abstract][Full Text] [Related]
40. Impact of perineural and lymphovascular invasion on oncological outcomes in rectal cancer treated with neoadjuvant chemoradiotherapy and surgery.
Cienfuegos JA; Rotellar F; Baixauli J; Beorlegui C; Sola JJ; Arbea L; Pastor C; Arredondo J; Hernández-Lizoáin JL
Ann Surg Oncol; 2015 Mar; 22(3):916-23. PubMed ID: 25190129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
